Home›Companies›Biotech & Pharma›Synedgen

Synedgen, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 1, 2024·Suggest an edit

About Synedgen

Synedgen is a private company based in Claremont, California. It has reported $24,336,397 raised in eight offerings on Form D since October 2009. Its chief executive is Shenda Baker.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 11, 2024Oct 1, 2024$1,750,000of $2.0M target4$437KDebtRule 506(b)Form D ↗
Jun 30, 2019Jul 12, 2019$2,500,000of $3.0M target1$2.5MRight to receive share of certain profits, out-licensing proceeds, intellectual property enforcement, and liquidation proceeds, in each case attributable to the issuer's wound care business division.Rule 506(b)Form D ↗
Aug 30, 2017Sep 12, 2017$3,000,000fully sold3$1.0MDebtRule 506(b)Form D ↗
Oct 28, 2016Nov 8, 2016$3,000,000of $3.5M target1$3.0MDebtRule 506(b)Form D ↗
Apr 13, 2016Apr 27, 2016$6,000,000of $6.5M target1$6.0MContractual RightsRule 506(b)Form D ↗
Feb 24, 2015Mar 3, 2015$3,500,000of $4.0M target1$3.5MEquityRule 506(b)Form D ↗
Aug 7, 2014Aug 13, 2014$607,440fully sold15$40,496EquityRule 506(b)Form D ↗
Oct 10, 2009Oct 20, 2009amended Jul 12, 2013$3,978,957of $4.0M target38$104KEquity06Form D/A ↗7 earlier filings
Total, eight offerings$24,336,397

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Synedgen's Form D filed Oct 1, 2024.

SB
Shenda Baker
Chief Executive Officer and President, director
WW
William Wiesmann
Executive officer and director
PG
Paul Grint
Director
HO
Hal Oien
Director
AM
DB
Kaveri Parker
Kaveri Parker
Executive officer
Also a chief business officer at Alume Biosciences.
KG

Earlier filings also listed William Wiesmann, M.D. (executive officer and director, last listed Jul 2019), Paul Grint, M.D. (director, last listed Jul 2019), Kenton Gregory, M.D. (director, last listed Jul 2019), Robert Coughlin (director, last listed Sep 2017), William Weismann (executive officer and director, last listed Nov 2016), Larry Shapiro (director, last listed Nov 2016), Diane Olmstead (director, last listed Apr 2016) and Clarke Atwell (director, last listed Apr 2016).

Sources

  1. SECSynedgen, Inc. Form D/A, filed Apr 29, 2013
  2. SECSynedgen, Inc. Form D/A, filed May 14, 2012
  3. SECSynedgen, Inc. Form D/A, filed May 14, 2012
  4. SECSynedgen, Inc. Form D/A, filed May 14, 2012
  5. SECSynedgen, Inc. Form D/A, filed May 14, 2012
  6. SECSynedgen, Inc. Form D/A, filed Sep 14, 2011
  7. SECSynedgen, Inc. Form D, filed Oct 20, 2009
  8. SECSynedgen, Inc. filing history